Point72 Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$493K	Sell	63,845 -158,318	-71%	-$1.16M	﹤0.01%	3125
2025 Q4	$1.36M	Buy	+222,163	New	+$2.4M	﹤0.01%	2704
2025 Q3	–	Sell	-6,154	Closed	-$80.1K	–	2319
2025 Q2	$80.1K	Sell	6,154 -4,163	-40%	-$49.2K	﹤0.01%	2082
2025 Q1	$109K	Buy	+10,317	New	+$164K	﹤0.01%	1906
2024 Q3	–	Sell	-244,154	Closed	-$5.95M	–	1976
2024 Q2	$5.95M	Sell	244,154 -91,224	-27%	-$2.77M	0.02%	789
2024 Q1	$11.3M	Buy	335,378 +317,800	+1,808%	+$11.3M	0.03%	670
2023 Q4	$554K	Sell	17,578 -317,700	-95%	-$7.55M	﹤0.01%	1553
2023 Q3	$8.57M	Buy	335,278 +330,875	+7,515%	+$10.2M	0.03%	708
2023 Q2	$126K	Sell	4,403 -75,985	-95%	-$2.07M	﹤0.01%	1503
2023 Q1	$1.93M	Buy	80,388 +15,888	+25%	+$285K	0.01%	985
2022 Q4	$1.09M	Sell	64,500 -552,624	-90%	-$9.64M	﹤0.01%	1033
2022 Q3	$9.15M	Sell	617,124 -296,199	-32%	-$4.97M	0.04%	530
2022 Q2	$14.4M	Buy	913,323 +488,123	+115%	+$9.58M	0.07%	399
2022 Q1	$11.5M	Buy	+425,200	New	+$10.9M	0.05%	473
2020 Q3	–	Sell	-223,013	Closed	-$10.4M	–	914
2020 Q2	$10.4M	Buy	+223,013	New	+$7.69M	0.07%	327